Azithromycin-induced liver injury
- Bupivacaine. // Reactions Weekly;3/18/2006, Issue 1093, p8
Discusses research being done on azithromyzin-induced hepatoxicity. Reference to study being done by A. M. Baciewicz et al., which appeared in the December 2005 issue of the "American Journal of Medicine"; Overview of the medical condition of a patient who developed hepatotoxity after receiving...
- Antibacterials/antituberculars. // Reactions Weekly;Jun2014, Vol. 1505 Issue 1, p6
The article presents a 36-year old man who developed signs and symptoms of drug-induced hepatotoxicity after he was treated with antibacterial therapy consisting of ceftriaxone and clindamycin and antitubercular therapy consisting of ethambutol, isoniazid, rifampicin and pyrazinamide.
- Hepatotoxicity of Antibacterials: Pathomechanisms and Clinical. Leitner, J. M.; Graninger, W.; Thalhammer, F. // Infection;Feb2010, Vol. 38 Issue 1, p3
Drug-induced hepatotoxicity is a frequent cause of liverdisease and acute liver failure, particularly in patients treatedwith multiple drugs. Several antibacterial drugs have thepotential to cause severe liver injury and failure. This articleaims to increase the awareness and understanding of...
- Azithromycin. // Reactions Weekly;3/18/2006, Issue 1093, p8
Discusses research being done on azithromycin-induced hepatotoxicity. Reference to a study by A. M. Baciewicz, A. Al-Nimr and P. Whelan published in the December 2005 issue of the "American Journal of Medicine"; Signs and symptoms; Result of the liver function test.
- Imatinib. // Reactions Weekly;Feb2014, Vol. 1488 Issue 1, p23
The article presents case studies of a 75-year old woman who developed liver damage and a 61-year old woman who developed hepatotoxicity during treatment with imatinib for chronic myelogenous leukaemia.
- Three cases of infection with pulmonary Mycobacterium Avium complex with resistance to macrolides secondary to prolonged prior use for bronchectasis. Manika, Katerina; Papavasileiou, Apostolos; Tsikrika, Stamatoula; Yannoulopoulou-Remoundou, Myrto; Konstantinou, Konstantinos // Pneumon;Apr-Jun2013, Vol. 26 Issue 2, p190
The activity of atypical or non tuberculous mycobacteria (NTM) as pulmonary pathogens has been recognized even in immunocompetent individuals. The Mycobaterium avium complex (MAC) is the commonest of the 130 NTMs and comprises two species, M. avium and M. intracellulare. For the treatment of...
- Ciclosporin/tacrolimus. // Reactions Weekly;8/9/2008, Issue 1214, p12
The article describes the case of a man who experienced hepatotoxicity during immunosuppression with tacrolimus. Hepatotoxicity recurred after his therapy was changed to ciclosporin. He developed swelling of hepatic and polynuclear cells and scattered necrosis. He received several treatment...
- Anti-Tuberculosis Drug Induced Hepatotoxicity and Genetic Polymorphisms in Drug-metabolizing Genes. Roy, B. // Current Pharmacogenomics;Jun2003, Vol. 1 Issue 2, p101
Anti-tuberculosis drug induced (ATD) hepatotoxicity is uncommon and unpredictable. It might be related to drug itself or reactive metabolites derived from the drugs in vivo. Several demographic characteristics, such as race, age, sex, body mass index, alcohol intake, have been reported to be...
- Ethambutol. // Reactions Weekly;5/21/2011, Issue 1352, p19
The article describes the case of an 84-year-old woman who developed irreversible optic neuropathy following treatment with ethambutol, rifampicin, isoniazid and pyrazinamide for tuberculosis osteomyelitis.